Effects of oxytocin receptor antagonist atosiban on pregnant myometrium invitro

Citation
U. Buscher et al., Effects of oxytocin receptor antagonist atosiban on pregnant myometrium invitro, OBSTET GYN, 98(1), 2001, pp. 117-121
Citations number
13
Categorie Soggetti
Reproductive Medicine","da verificare
Journal title
OBSTETRICS AND GYNECOLOGY
ISSN journal
00297844 → ACNP
Volume
98
Issue
1
Year of publication
2001
Pages
117 - 121
Database
ISI
SICI code
0029-7844(200107)98:1<117:EOORAA>2.0.ZU;2-K
Abstract
OBJECTIVE: To investigate dose-dependent effects of oxytocin receptor antag onist, atosiban, on oxytocin-induced contractions of myometrial strips from healthy pregnant women. METHODS: During elective cesareans, myometrial biopsies were taken from the lower uterine segment and trimmed into 2 x 2 x 10-mm longitudinal strips w ithin 36 hours. One hundred twenty-two myometrial strips showed regular spo ntaneous contractions and were used for measurement. Each myometrial strip was mounted in a physiologic organ bath, and isometric contraction activity and contractile patterns were analyzed after stimulation with oxytocin. Fr equency and amplitude of contractions and area under force-time curves were determined by adding atosiban at concentrations of 1, 5, 10, 20, 50, 100, 250, and 500 mug/mL. Resulting contraction activity (at least 20 contractio ns per concentration) was compared with reference activity. RESULTS: Atosiban had significant inhibitory effects on myometrial contract ions at concentrations as low as 1 mug/mL. Compared with reference activity (oxytocin stimulation only), resulting inhibition was higher than 50% with the lowest atosiban concentration used. This inhibition of contraction act ivity was dose-dependent and referred to the area under the curve, frequenc y, and amplitude of contractions. At high concentrations of atosiban, contr action activity was even lower than spontaneous activity without oxytocin s timulation. CONCLUSION: The oxytocin receptor antagonist atosiban showed a significant, dose-dependent inhibition of oxytocin-induced contractions of human myomet rium in vitro. It might be effective into tolysis at term. (C) 2001 by the American College of Obstetridans and Gynecologists.